Department of General Surgery, Breast and Endocrine Surgery Unit, Marmara University School of Medicine, Istanbul, Turkey.
Department of Radiology, Marmara University School of Medicine, Istanbul, Turkey.
Breast Cancer Res Treat. 2023 Oct;201(3):417-424. doi: 10.1007/s10549-023-07041-8. Epub 2023 Jul 25.
Indications for nipple sparing mastectomy (NSM) is extending to post-neoadjuvant chemotherapy (NAC) setting. Eligibility for NSM with an optimum tumor-nipple distance (TND) after NAC is unclear. We examined predictive factors for nipple tumor involvement in patients undergoing total mastectomy following NAC.
Clinical and pathological data from prospectively collected medical records of women with invasive breast carcinoma, who were undergone NAC and total mastectomy with sentinel lymph node biopsy and/or axillary lymph node dissection were analyzed. PreNAC and postNAC magnetic resonance imaging (MRI) views were examined and a cut-off TND value for predicting the negative nipple tumor status was determined.
Among 180 women, the final mastectomy specimen analysis revealed that 12 (7%) had nipple involvement as invasive carcinoma. Patients with nipple involvement had more postNAC multifocal/multicentric tumors (p: 0.03), larger tumors on preNAC and postNAC images (p: 0.002 and p < 0.001), shorter median TNDs on preNAC and postNAC images (7 mm-IQR 1.5-14, p: 0.005 and 8.5 mm-IQR 3-15.5, p < 0.001, respectively), more nipple retraction on preNAC and postNAC images (p: 0.007 and p: 0.006) and more nipple areola complex skin thickening (> 2mm) on preNAC and postNAC images (p < 0.001 and p: 0.01). The best likelihood ratios (LR) belonged to the postNAC positivity of the < 20 mm TND, with a + LR of 3.40, and - LR of 0.11 for nipple involvement. PreNAC positivity of the < 20 mm TND also had a similar - LR of 0.14.
A TND-cut-off ≥ 2 cm on preNAC and postNAC MRI was shown to be highly predictive of negative nipple tumor involvement.
保乳乳头切除术(NSM)的适应证正在扩展到新辅助化疗(NAC)后。NAC 后具有最佳肿瘤乳头距离(TND)的 NSM 的适应证尚不清楚。我们检查了在 NAC 后行全乳切除术的患者中乳头肿瘤受累的预测因素。
对前瞻性收集的接受 NAC 及前哨淋巴结活检和/或腋窝淋巴结清扫的浸润性乳腺癌女性的病历进行临床和病理数据分析。检查了新辅助化疗前和新辅助化疗后的磁共振成像(MRI)视图,并确定了用于预测阴性乳头肿瘤状态的 TND 截断值。
在 180 名女性中,最终的乳房切除术标本分析显示 12 名(7%)有乳头受累的浸润性癌。有乳头受累的患者在新辅助化疗后有更多的多灶性/多中心肿瘤(p:0.03),新辅助化疗前和新辅助化疗后的肿瘤更大(p:0.002 和 p < 0.001),新辅助化疗前和新辅助化疗后的 TND 中位数更短(7 毫米 IQR 1.5-14,p:0.005 和 8.5 毫米 IQR 3-15.5,p < 0.001,分别),新辅助化疗前和新辅助化疗后的乳头回缩更多(p:0.007 和 p:0.006),新辅助化疗前和新辅助化疗后的乳晕复合体皮肤增厚(> 2 毫米)更多(p < 0.001 和 p:0.01)。最佳似然比(LR)属于新辅助化疗后 < 20 毫米 TND 的阳性,有乳头受累的+LR 为 3.40,-LR 为 0.11。新辅助化疗后 < 20 毫米 TND 的阳性也有类似的 -LR 为 0.14。
新辅助化疗前和新辅助化疗后 MRI 的 TND 截断值 ≥ 2 厘米,高度预测阴性乳头肿瘤受累。